Injectable Decellularized Nerve Hydrogel for Regeneration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for peripheral nerve repair, such as nerve autografting and synthetic guidance conduits, often result in disappointing functional outcomes due to immunogenic reactions, foreign body reactions, and limited regeneration, especially for critically sized defects.

Innovation Solution

A decellularized peripheral nerve-specific scaffold is formulated into an injectable hydrogel form, which is non-cytotoxic and supports neuronal outgrowth, reducing muscular atrophy and promoting nerve regrowth by maintaining nerve-specific components and structural integrity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If nerve autografting is used for critically sized defects, then nerve regeneration is possible, but donor site morbidity and immune response occur

Engineering Contradiction:
Improvenerve regeneration successVSAvoidimmune response and donor site morbidity
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent extracts the beneficial extracellular matrix components from native nerve tissue through decellularization, removing immunogenic cellular elements while retaining the structural and biochemical framework needed for nerve regeneration. This creates an acellular scaffold that eliminates donor site morbidity and reduces immune rejection while maintaining regenerative capacity.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The decellularized nerve scaffold acts as an intermediary between the host immune system and the nerve regeneration process. By removing cellular components that trigger immune responses while preserving the extracellular matrix architecture, the scaffold mediates between avoiding immunogenicity and supporting axonal growth.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If synthetic guidance conduits are used, then nerve regeneration support is provided, but foreign body reaction and limited regeneration occur

Engineering Contradiction:
Improvenerve regeneration supportVSAvoidforeign body reaction
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent creates a composite material by combining synthetic conduit structure with biologically derived extracellular matrix components. The synthetic provides mechanical integrity and guidance, while the decellularized nerve tissue adds bioactivity and reduces foreign body reaction, achieving both structural support and biological compatibility.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent changes the biochemical parameters of the scaffold by incorporating nerve-specific extracellular matrix components with particular concentrations of growth factors and structural proteins. This optimization of compositional parameters enhances nerve regeneration support while minimizing immunogenicity compared to generic synthetic materials.

Inventive Principle:
Principle #35Parameter changes

3Object-affected harmful factors

If decellularized tissue scaffold is used, then immunogenic cellular components are removed, but nerve-specific components must be retained

Engineering Contradiction:
Improveimmunogenicity reductionVSAvoidnerve regrowth support
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent selectively extracts cellular components from nerve tissue through controlled decellularization processes, removing nuclei and cytoplasmic elements that cause immune responses while deliberately preserving the extracellular matrix, growth factors, and structural proteins essential for nerve regeneration.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent applies different properties to different components of the tissue: cellular elements are made immunogenic-free through removal, while extracellular matrix regions are preserved to maintain their native nerve-specific biochemical and structural qualities that support axonal guidance and regeneration.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The hydrogel effectively supports nerve repair and functional recovery by minimizing immunogenic responses and promoting axonal regrowth, as demonstrated in a canine model of recurrent laryngeal nerve injury, with improved muscle fiber diameter and reinnervation amplitudes compared to control groups.

Implementation Method 1

the decellularized tissue scaffold is formulated into a hydrogel through the use of enzymatic degradation

Methodology Applied
Scientific EffectEnzymatic degradation: Enzyme

Implementation Method 2

supports the growth of neurons and speeds recovery following surgical reconstruction

Methodology Applied
Scientific EffectCell migration:

Data Source

PatentUS11338058B2Injectable peripheral nerve specific hydrogel
Publication Date: 2022.05.24 UNIV OF PITTSBURGH OF THE COMMONWEALTH SYST OF HIGHER EDUCATION
  • US11338058B2 patent drawing
  • US11338058B2 patent drawing
  • US11338058B2 patent drawing

AI summary

The present invention relates to a peripheral nerve-specific hydrogel material, which is deliverable in a minimally invasive fashion, sustains the growth of neurons, and speeds recovery following surgical reconstruction.